Quanex Building Products CORP
For the period ended Jul 31, 2025. Filed Sep 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jul 31, 2025 · Filed Sep 5, 2025
NX$21.17-3.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows – Nine
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
| Nine Months Ended | ||
|---|---|---|
| July 31, | ||
| 2025 | 2024 | |
| (In thousands) | ||
| Operating activities: | ||
| Net (loss) income | $(270,377) | $46,976 |
| Adjustments to reconcile net (loss) income to cash provided by operating activities: | ||
| Depreciation and amortization | 77,814 | 32,999 |
| Stock-based compensation | 2,762 | 2,159 |
| Deferred income tax | (26,440) | (2,321) |
| Asset impairment charges | 302,284 | — |
| Gain on deal contingent foreign exchange forward currency contract | — | (9,200) |
| Other, net | 9,203 | 886 |
| Changes in assets and liabilities: | ||
| (Increase) decrease in accounts receivable | (1,727) | 11,114 |
| Decrease (increase) in inventory | 5,261 | (183) |
| (Increase) decrease in other current assets | (7,228) | 1,646 |
| Increase (decrease) in accounts payable | 144 | (9,634) |
| (Decrease) increase in accrued liabilities | (9,725) | 948 |
| (Decrease) increase in income taxes payable | (21) | 6,659 |
| (Decrease) increase in other long-term liabilities | (5,395) | 707 |
| Other, net | 88 | 577 |
| Cash provided by operating activities | 76,643 | 83,333 |
| Investing activities: | ||
| Capital expenditures | (40,996) | (23,435) |
| Proceeds from disposition of capital assets | 361 | 115 |
| Cash used for investing activities | (40,635) | (23,320) |
| Financing activities: | ||
| Borrowings under credit facilities | 170,000 | — |
| Repayments of credit facility borrowings | (213,750) | (15,000) |
| Repayments of other long-term debt | (1,962) | (1,893) |
| Common stock dividends paid | (11,233) | (7,943) |
| Issuance of common stock | 214 | 573 |
| Payroll tax paid to settle shares forfeited upon vesting of stock | (1,400) | (1,193) |
| Purchase of treasury stock | (29,248) | — |
| Cash used for financing activities | (87,379) | (25,456) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 16,302 | 935 |
| (Decrease) increase in cash, cash equivalents and restricted cash | (35,069) | 35,492 |
| Cash, cash equivalents and restricted cash at beginning of period | 102,995 | 58,474 |
| Cash, cash equivalents and restricted cash at end of period | $67,926 | $93,966 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.